|
US4356167A
(en)
*
|
1978-01-27 |
1982-10-26 |
Sandoz, Inc. |
Liposome drug delivery systems
|
|
IT1111367B
(it)
*
|
1978-11-17 |
1986-01-13 |
Serono Ist Farm |
Processo per la preparazione estemporanea di liposomi e liposomi cosi' ottenuti
|
|
EP0032578B1
(de)
|
1980-01-16 |
1984-07-25 |
Hans Georg Prof. Dr. Weder |
Verfahren und Dialysiereinrichtung zur Herstellung von Bilayer-Vesikeln und Verwendung der Bilayer-Vesikel
|
|
US4302459A
(en)
*
|
1980-03-19 |
1981-11-24 |
The United States Of America As Represented By The Secretary Of The Army |
Liposome carriers in leishmaniasis chemotherapy with 8-aminoquinoline derivatives
|
|
DE3161962D1
(en)
*
|
1980-07-01 |
1984-02-23 |
Oreal |
Process for obtaining stable dispersions in an aqueous phase of at least a water immiscible liquid phase, and corresponding dispersions
|
|
DE3173713D1
(en)
*
|
1980-09-05 |
1986-03-20 |
Frappier Armand Inst |
Formation of an immunosome exclusively made of viral antigens reconstituted on an artificial membrane
|
|
US4394372A
(en)
*
|
1980-12-22 |
1983-07-19 |
The Procter & Gamble Company |
Process for making lipid membrane structures
|
|
GR77320B
(fi)
*
|
1980-12-22 |
1984-09-11 |
Procter & Gamble |
|
|
GB2103485B
(en)
*
|
1981-08-10 |
1986-04-03 |
Wellcone Foundation Limited Th |
Liposomes containing antimonyanti-leishmanaisis drugs
|
|
NL193099C
(nl)
*
|
1981-10-30 |
1998-11-03 |
Novo Industri As |
Gestabiliseerde insuline-oplossing.
|
|
EP0088046B1
(de)
*
|
1982-02-17 |
1987-12-09 |
Ciba-Geigy Ag |
Lipide in wässriger Phase
|
|
US4416872A
(en)
*
|
1982-03-17 |
1983-11-22 |
The United States Of America As Represented By The Secretary Of The Army |
Treatment of malaria with liposomes containing 8-aminoquinoline derivatives and glycoconjugates
|
|
WO1983003383A1
(en)
*
|
1982-03-29 |
1983-10-13 |
Liposome Co Inc |
Stable plurilamellar vesicles
|
|
US4522803A
(en)
*
|
1983-02-04 |
1985-06-11 |
The Liposome Company, Inc. |
Stable plurilamellar vesicles, their preparation and use
|
|
US5441745A
(en)
*
|
1982-03-30 |
1995-08-15 |
Vestar, Inc. |
Method of delivering micellular particles encapsulating chemotherapeutic agents to tumors in a body
|
|
US5435989A
(en)
*
|
1982-03-30 |
1995-07-25 |
Vestar, Inc. |
Method of targeting a specific location in a body
|
|
US4612370A
(en)
*
|
1982-04-02 |
1986-09-16 |
The Regents Of The University Of California |
Lipid-saccharide reaction products
|
|
US4425334A
(en)
|
1982-04-02 |
1984-01-10 |
The Regents Of The University Of California |
Functional oxygen transport system
|
|
US4522811A
(en)
*
|
1982-07-08 |
1985-06-11 |
Syntex (U.S.A.) Inc. |
Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
|
|
EP0100964A3
(de)
*
|
1982-07-31 |
1984-06-13 |
Reifenrath, Rainer, Dr. |
Pharmazeutisches Erzeugnis zur Behandlung und Prophylaxe von Infektionen sowie von Husten und obstruktiven Atemwegserkrankungen sowie Verfahren zu seiner Herstellung
|
|
US4485054A
(en)
*
|
1982-10-04 |
1984-11-27 |
Lipoderm Pharmaceuticals Limited |
Method of encapsulating biologically active materials in multilamellar lipid vesicles (MLV)
|
|
US4501728A
(en)
*
|
1983-01-06 |
1985-02-26 |
Technology Unlimited, Inc. |
Masking of liposomes from RES recognition
|
|
FR2540381B1
(fr)
*
|
1983-02-08 |
1986-05-30 |
Dior Sa Parfums Christian |
Procede pour stimuler la croissance des cellules; composition cosmetique, pharmaceutique et composition complementaire pour milieu de culture cellulaire appliquant ce procede
|
|
US5387410A
(en)
*
|
1983-03-18 |
1995-02-07 |
Mallinckrodt, Inc. |
Method for enhancing magnetic resonance with compositions containing paramagnetic elements carried by liposomes
|
|
US4588578A
(en)
*
|
1983-08-08 |
1986-05-13 |
The Liposome Company, Inc. |
Lipid vesicles prepared in a monophase
|
|
US5186941A
(en)
*
|
1983-05-06 |
1993-02-16 |
Vestar, Inc. |
Vesicle formulation for the controlled release of therapeutic agents
|
|
FR2561101B1
(fr)
*
|
1984-03-13 |
1986-10-31 |
Paris Sud Universite |
Procede de preparation de liposomes et liposomes ainsi obtenus
|
|
US4610868A
(en)
*
|
1984-03-20 |
1986-09-09 |
The Liposome Company, Inc. |
Lipid matrix carriers for use in drug delivery systems
|
|
US5231112A
(en)
*
|
1984-04-12 |
1993-07-27 |
The Liposome Company, Inc. |
Compositions containing tris salt of cholesterol hemisuccinate and antifungal
|
|
US4921706A
(en)
*
|
1984-11-20 |
1990-05-01 |
Massachusetts Institute Of Technology |
Unilamellar lipid vesicles and method for their formation
|
|
US4857319A
(en)
*
|
1985-01-11 |
1989-08-15 |
The Regents Of The University Of California |
Method for preserving liposomes
|
|
US4707453A
(en)
*
|
1985-04-05 |
1987-11-17 |
Becton Dickinson And Company |
Vesicle including a metal marker for use in an assay
|
|
US4698263A
(en)
*
|
1985-05-23 |
1987-10-06 |
Becton Dickinson And Company |
Sac having a marker linked thereto
|
|
US5409704A
(en)
*
|
1985-06-26 |
1995-04-25 |
The Liposome Company, Inc. |
Liposomes comprising aminoglycoside phosphates and methods of production and use
|
|
US5041278A
(en)
*
|
1985-10-15 |
1991-08-20 |
The Liposome Company, Inc. |
Alpha tocopherol-based vesicles
|
|
US4861580A
(en)
*
|
1985-10-15 |
1989-08-29 |
The Liposome Company, Inc. |
Composition using salt form of organic acid derivative of alpha-tocopheral
|
|
FR2591105B1
(fr)
|
1985-12-11 |
1989-03-24 |
Moet Hennessy Rech |
Composition pharmaceutique, notamment dermatologique, ou cosmetique, a base de phases lamellaires lipidiques hydratees ou de liposomes contenant un retinoide ou un analogue structural dudit retinoide tel qu'un carotenoide.
|
|
JPH0751496B2
(ja)
*
|
1986-04-02 |
1995-06-05 |
武田薬品工業株式会社 |
リポソ−ムの製造法
|
|
FR2597345B1
(fr)
*
|
1986-04-22 |
1990-08-03 |
Oreal |
Composition cosmetique ou pharmaceutique a base d'une dispersion aqueuse de spherules lipidiques.
|
|
US6759057B1
(en)
|
1986-06-12 |
2004-07-06 |
The Liposome Company, Inc. |
Methods and compositions using liposome-encapsulated non-steroidal anti-inflammatory drugs
|
|
EP0269720B1
(en)
*
|
1986-06-16 |
1992-02-19 |
The Liposome Company, Inc. |
Induction of asymmetry in vesicles
|
|
US5252263A
(en)
*
|
1986-06-16 |
1993-10-12 |
The Liposome Company, Inc. |
Induction of asymmetry in vesicles
|
|
US5204112A
(en)
*
|
1986-06-16 |
1993-04-20 |
The Liposome Company, Inc. |
Induction of asymmetry in vesicles
|
|
DE3777640D1
(fi)
*
|
1986-11-28 |
1992-04-23 |
The Liposome Co.,Inc., Princeton, N.J., Us |
|
|
US4783220A
(en)
*
|
1986-12-18 |
1988-11-08 |
Xerox Corporation |
Vesicle ink compositions
|
|
WO1988004573A1
(en)
*
|
1986-12-23 |
1988-06-30 |
The Liposome Company, Inc. |
Liposome preparation and antibiotic
|
|
US5723147A
(en)
*
|
1987-02-23 |
1998-03-03 |
Depotech Corporation |
Multivesicular liposomes having a biologically active substance encapsulated therein in the presence of a hydrochloride
|
|
GB8704171D0
(en)
*
|
1987-02-23 |
1987-04-01 |
Clayton Found Res |
Multivesicular liposomes
|
|
US4963297A
(en)
*
|
1987-12-22 |
1990-10-16 |
The Liposome Company, Inc. |
Spontaneous vesticulation of multilamellar liposomes
|
|
US5616334A
(en)
*
|
1987-03-05 |
1997-04-01 |
The Liposome Company, Inc. |
Low toxicity drug-lipid systems
|
|
US6406713B1
(en)
|
1987-03-05 |
2002-06-18 |
The Liposome Company, Inc. |
Methods of preparing low-toxicity drug-lipid complexes
|
|
MX9203808A
(es)
*
|
1987-03-05 |
1992-07-01 |
Liposome Co Inc |
Formulaciones de alto contenido de medicamento: lipido, de agentes liposomicos-antineoplasticos.
|
|
US5925375A
(en)
*
|
1987-05-22 |
1999-07-20 |
The Liposome Company, Inc. |
Therapeutic use of multilamellar liposomal prostaglandin formulations
|
|
MX9203804A
(es)
*
|
1987-10-19 |
1992-07-01 |
Liposome Co Inc |
Sistemas farmaceuticos a base de tocoferol.
|
|
US4873035A
(en)
*
|
1987-11-25 |
1989-10-10 |
Abbott Laboratories |
Preparation of sized populations of liposomes
|
|
US5017501A
(en)
*
|
1987-11-25 |
1991-05-21 |
Abbott Laboratories |
Preparation of uniformly sized liposomes encapsulating an aqueous liquid
|
|
KR900000848B1
(ko)
*
|
1987-12-30 |
1990-02-17 |
태평양화학 주식회사 |
리포좀을 함유한 화장료의 제조방법
|
|
US5807572A
(en)
*
|
1988-02-18 |
1998-09-15 |
Depotech Corporation |
Multivesicular liposomes having a biologically active substance encapsulated therein in the presence of a hydrochloride
|
|
US5013497A
(en)
*
|
1988-03-03 |
1991-05-07 |
Micro-Pak, Inc. |
Method and apparatus for producing lipid vesicles
|
|
US5948441A
(en)
*
|
1988-03-07 |
1999-09-07 |
The Liposome Company, Inc. |
Method for size separation of particles
|
|
US5422120A
(en)
*
|
1988-05-30 |
1995-06-06 |
Depotech Corporation |
Heterovesicular liposomes
|
|
CA1339034C
(en)
*
|
1988-08-22 |
1997-04-01 |
Paul A. Tremblay |
Platinum complexes of single isomer neoalkyl acids
|
|
US4906476A
(en)
*
|
1988-12-14 |
1990-03-06 |
Liposome Technology, Inc. |
Novel liposome composition for sustained release of steroidal drugs in lungs
|
|
US5043165A
(en)
*
|
1988-12-14 |
1991-08-27 |
Liposome Technology, Inc. |
Novel liposome composition for sustained release of steroidal drugs
|
|
US5116615A
(en)
*
|
1989-01-27 |
1992-05-26 |
Immunolytics, Inc. |
Method for treating benign prostatic hypertrophy
|
|
AU5045690A
(en)
|
1989-01-27 |
1990-08-24 |
Immunolytics, Inc. |
Composition and method for treating benign prostatic hypertrophy
|
|
US5078986A
(en)
*
|
1989-02-15 |
1992-01-07 |
Mallinckrodt Medical, Inc. |
Method for enhancing magnetic resonance imaging using an image altering agent containing an excess of chelating agent
|
|
US5100662A
(en)
*
|
1989-08-23 |
1992-03-31 |
The Liposome Company, Inc. |
Steroidal liposomes exhibiting enhanced stability
|
|
US5188837A
(en)
*
|
1989-11-13 |
1993-02-23 |
Nova Pharmaceutical Corporation |
Lipsopheres for controlled delivery of substances
|
|
US5227165A
(en)
*
|
1989-11-13 |
1993-07-13 |
Nova Pharmaceutical Corporation |
Liposphere delivery systems for local anesthetics
|
|
US5221535A
(en)
*
|
1989-11-13 |
1993-06-22 |
Nova Pharmaceutical Corporation |
Sustained release formulations of insect repellent
|
|
IE904098A1
(en)
*
|
1989-11-13 |
1991-05-22 |
Nova Pharm Corp |
Lipospheres for controlled delivery of substances
|
|
US5733572A
(en)
*
|
1989-12-22 |
1998-03-31 |
Imarx Pharmaceutical Corp. |
Gas and gaseous precursor filled microspheres as topical and subcutaneous delivery vehicles
|
|
US5776429A
(en)
*
|
1989-12-22 |
1998-07-07 |
Imarx Pharmaceutical Corp. |
Method of preparing gas-filled microspheres using a lyophilized lipids
|
|
US5469854A
(en)
*
|
1989-12-22 |
1995-11-28 |
Imarx Pharmaceutical Corp. |
Methods of preparing gas-filled liposomes
|
|
US5580575A
(en)
*
|
1989-12-22 |
1996-12-03 |
Imarx Pharmaceutical Corp. |
Therapeutic drug delivery systems
|
|
US6001335A
(en)
*
|
1989-12-22 |
1999-12-14 |
Imarx Pharmaceutical Corp. |
Contrasting agents for ultrasonic imaging and methods for preparing the same
|
|
US20020150539A1
(en)
|
1989-12-22 |
2002-10-17 |
Unger Evan C. |
Ultrasound imaging and treatment
|
|
US5705187A
(en)
*
|
1989-12-22 |
1998-01-06 |
Imarx Pharmaceutical Corp. |
Compositions of lipids and stabilizing materials
|
|
US5305757A
(en)
*
|
1989-12-22 |
1994-04-26 |
Unger Evan C |
Gas filled liposomes and their use as ultrasonic contrast agents
|
|
US5773024A
(en)
*
|
1989-12-22 |
1998-06-30 |
Imarx Pharmaceutical Corp. |
Container with multi-phase composition for use in diagnostic and therapeutic applications
|
|
US6146657A
(en)
*
|
1989-12-22 |
2000-11-14 |
Imarx Pharmaceutical Corp. |
Gas-filled lipid spheres for use in diagnostic and therapeutic applications
|
|
US6551576B1
(en)
|
1989-12-22 |
2003-04-22 |
Bristol-Myers Squibb Medical Imaging, Inc. |
Container with multi-phase composition for use in diagnostic and therapeutic applications
|
|
US5922304A
(en)
|
1989-12-22 |
1999-07-13 |
Imarx Pharmaceutical Corp. |
Gaseous precursor filled microspheres as magnetic resonance imaging contrast agents
|
|
US6088613A
(en)
|
1989-12-22 |
2000-07-11 |
Imarx Pharmaceutical Corp. |
Method of magnetic resonance focused surgical and therapeutic ultrasound
|
|
US5352435A
(en)
*
|
1989-12-22 |
1994-10-04 |
Unger Evan C |
Ionophore containing liposomes for ultrasound imaging
|
|
US5656211A
(en)
*
|
1989-12-22 |
1997-08-12 |
Imarx Pharmaceutical Corp. |
Apparatus and method for making gas-filled vesicles of optimal size
|
|
US5585112A
(en)
*
|
1989-12-22 |
1996-12-17 |
Imarx Pharmaceutical Corp. |
Method of preparing gas and gaseous precursor-filled microspheres
|
|
US5542935A
(en)
*
|
1989-12-22 |
1996-08-06 |
Imarx Pharmaceutical Corp. |
Therapeutic delivery systems related applications
|
|
NZ237464A
(en)
*
|
1990-03-21 |
1995-02-24 |
Depotech Corp |
Liposomes with at least two separate chambers encapsulating two separate biologically active substances
|
|
US20040208826A1
(en)
*
|
1990-04-02 |
2004-10-21 |
Bracco International B.V. |
Ultrasound contrast agents and methods of making and using them
|
|
US20010024638A1
(en)
*
|
1992-11-02 |
2001-09-27 |
Michel Schneider |
Stable microbubble suspensions as enhancement agents for ultrasound echography and dry formulations thereof
|
|
US5578292A
(en)
|
1991-11-20 |
1996-11-26 |
Bracco International B.V. |
Long-lasting aqueous dispersions or suspensions of pressure-resistant gas-filled microvesicles and methods for the preparation thereof
|
|
US5445813A
(en)
*
|
1992-11-02 |
1995-08-29 |
Bracco International B.V. |
Stable microbubble suspensions as enhancement agents for ultrasound echography
|
|
IN172208B
(fi)
*
|
1990-04-02 |
1993-05-01 |
Sint Sa |
|
|
US6613306B1
(en)
|
1990-04-02 |
2003-09-02 |
Bracco International B.V. |
Ultrasound contrast agents and methods of making and using them
|
|
US6989141B2
(en)
*
|
1990-05-18 |
2006-01-24 |
Bracco International B.V. |
Ultrasound contrast agents and methods of making and using them
|
|
USRE39146E1
(en)
|
1990-04-02 |
2006-06-27 |
Bracco International B.V. |
Long-lasting aqueous dispersions or suspensions of pressure-resistant gas-filled microvesicles and methods for the preparation thereof
|
|
US7083778B2
(en)
*
|
1991-05-03 |
2006-08-01 |
Bracco International B.V. |
Ultrasound contrast agents and methods of making and using them
|
|
AU636481B2
(en)
*
|
1990-05-18 |
1993-04-29 |
Bracco International B.V. |
Polymeric gas or air filled microballoons usable as suspensions in liquid carriers for ultrasonic echography
|
|
US20030194376A1
(en)
*
|
1990-05-18 |
2003-10-16 |
Bracco International B.V. |
Ultrasound contrast agents and methods of making and using them
|
|
WO1992002244A1
(en)
*
|
1990-07-31 |
1992-02-20 |
The Liposome Company, Inc. |
Accumulation of amino acids and peptides into liposomes
|
|
ES2089226T3
(es)
*
|
1990-09-06 |
1996-10-01 |
Johnson & Son Inc S C |
Procedimiento para estabilizar liposomas y composiciones que los contienen.
|
|
US5205290A
(en)
|
1991-04-05 |
1993-04-27 |
Unger Evan C |
Low density microspheres and their use as contrast agents for computed tomography
|
|
US5874062A
(en)
*
|
1991-04-05 |
1999-02-23 |
Imarx Pharmaceutical Corp. |
Methods of computed tomography using perfluorocarbon gaseous filled microspheres as contrast agents
|
|
US5567432A
(en)
*
|
1991-08-02 |
1996-10-22 |
Lau; John R. |
Masking of liposomes from RES recognition
|
|
IL104084A
(en)
|
1992-01-24 |
1996-09-12 |
Bracco Int Bv |
Sustainable aqueous suspensions of pressure-resistant and gas-filled blisters, their preparation, and contrast agents containing them
|
|
US5455044A
(en)
*
|
1993-05-14 |
1995-10-03 |
Depotech Corporation |
Method for treating neurological disorders
|
|
JPH08510748A
(ja)
*
|
1993-05-21 |
1996-11-12 |
ザ リポソーム カンパニー、インコーポレーテッド |
リポソームが誘発する生理的副作用の低減
|
|
RU2160093C2
(ru)
*
|
1993-11-16 |
2000-12-10 |
Скайефарма Инк. |
Везикулы с регулируемым высвобождением активных ингредиентов
|
|
US7083572B2
(en)
|
1993-11-30 |
2006-08-01 |
Bristol-Myers Squibb Medical Imaging, Inc. |
Therapeutic delivery systems
|
|
ES2192572T3
(es)
*
|
1993-12-15 |
2003-10-16 |
Bracco Research Sa |
Medios de contraste de ultrasonidos, agentes de contraste que contienen los medios, y metodo.
|
|
JP3591837B2
(ja)
*
|
1994-02-17 |
2004-11-24 |
ニューヨーク・ブラッド・センター・インコーポレイテッド |
フィブリン膠およびリポソームを含有する生物学的生体接着剤組成物、その製造方法および使用
|
|
US5736121A
(en)
*
|
1994-05-23 |
1998-04-07 |
Imarx Pharmaceutical Corp. |
Stabilized homogenous suspensions as computed tomography contrast agents
|
|
US6951743B2
(en)
|
1997-10-31 |
2005-10-04 |
University Of Oklahoma Board Of Regents |
Hyaluronan synthase genes and expression thereof in bacillus hosts
|
|
US7091008B1
(en)
*
|
1994-07-01 |
2006-08-15 |
The Board Of Regents Of The University Of Oklahoma |
Hyaluronan synthase genes and expression thereof in Bacillus hosts
|
|
US6455304B1
(en)
*
|
1994-07-01 |
2002-09-24 |
The Board Of Regents Of The University Of Oklahoma |
Hyaluronate synthase gene and uses thereof
|
|
US5993850A
(en)
*
|
1994-09-13 |
1999-11-30 |
Skyepharma Inc. |
Preparation of multivesicular liposomes for controlled release of encapsulated biologically active substances
|
|
US6743779B1
(en)
|
1994-11-29 |
2004-06-01 |
Imarx Pharmaceutical Corp. |
Methods for delivering compounds into a cell
|
|
US5830430A
(en)
*
|
1995-02-21 |
1998-11-03 |
Imarx Pharmaceutical Corp. |
Cationic lipids and the use thereof
|
|
US5800833A
(en)
*
|
1995-02-27 |
1998-09-01 |
University Of British Columbia |
Method for loading lipid vesicles
|
|
US5824638A
(en)
*
|
1995-05-22 |
1998-10-20 |
Shire Laboratories, Inc. |
Oral insulin delivery
|
|
US5997898A
(en)
*
|
1995-06-06 |
1999-12-07 |
Imarx Pharmaceutical Corp. |
Stabilized compositions of fluorinated amphiphiles for methods of therapeutic delivery
|
|
US6033645A
(en)
*
|
1996-06-19 |
2000-03-07 |
Unger; Evan C. |
Methods for diagnostic imaging by regulating the administration rate of a contrast agent
|
|
US6139819A
(en)
*
|
1995-06-07 |
2000-10-31 |
Imarx Pharmaceutical Corp. |
Targeted contrast agents for diagnostic and therapeutic use
|
|
US6521211B1
(en)
|
1995-06-07 |
2003-02-18 |
Bristol-Myers Squibb Medical Imaging, Inc. |
Methods of imaging and treatment with targeted compositions
|
|
US6231834B1
(en)
|
1995-06-07 |
2001-05-15 |
Imarx Pharmaceutical Corp. |
Methods for ultrasound imaging involving the use of a contrast agent and multiple images and processing of same
|
|
CA2227013A1
(en)
|
1995-07-14 |
1997-02-06 |
Glycotech Corp. |
Compounds and methods for treatment of egf receptor associated cancers and purification of the egf receptor
|
|
US5931809A
(en)
*
|
1995-07-14 |
1999-08-03 |
Depotech Corporation |
Epidural administration of therapeutic compounds with sustained rate of release
|
|
US6022500A
(en)
*
|
1995-09-27 |
2000-02-08 |
The United States Of America As Represented By The Secretary Of The Army |
Polymer encapsulation and polymer microsphere composites
|
|
US6447800B2
(en)
|
1996-01-18 |
2002-09-10 |
The University Of British Columbia |
Method of loading preformed liposomes using ethanol
|
|
US6143287A
(en)
*
|
1996-02-27 |
2000-11-07 |
New York Blood Center, Inc. |
Method and composition for hair removal
|
|
WO1997040679A1
(en)
|
1996-05-01 |
1997-11-06 |
Imarx Pharmaceutical Corp. |
Methods for delivering compounds into a cell
|
|
US6414139B1
(en)
|
1996-09-03 |
2002-07-02 |
Imarx Therapeutics, Inc. |
Silicon amphiphilic compounds and the use thereof
|
|
US5846517A
(en)
*
|
1996-09-11 |
1998-12-08 |
Imarx Pharmaceutical Corp. |
Methods for diagnostic imaging using a renal contrast agent and a vasodilator
|
|
ES2189974T3
(es)
*
|
1996-09-11 |
2003-07-16 |
Imarx Pharmaceutical Corp |
Procedimientos mejorados para la obtencion de imagenes de diagnostico usando un agente de contraste y un vasodilatador.
|
|
US5997899A
(en)
|
1996-10-01 |
1999-12-07 |
Skyepharma Inc. |
Method for producing liposomes with increased percent of compound encapsulated
|
|
US5891467A
(en)
|
1997-01-31 |
1999-04-06 |
Depotech Corporation |
Method for utilizing neutral lipids to modify in vivo release from multivesicular liposomes
|
|
US6120751A
(en)
|
1997-03-21 |
2000-09-19 |
Imarx Pharmaceutical Corp. |
Charged lipids and uses for the same
|
|
US6537246B1
(en)
|
1997-06-18 |
2003-03-25 |
Imarx Therapeutics, Inc. |
Oxygen delivery agents and uses for the same
|
|
US6143276A
(en)
*
|
1997-03-21 |
2000-11-07 |
Imarx Pharmaceutical Corp. |
Methods for delivering bioactive agents to regions of elevated temperatures
|
|
US6090800A
(en)
*
|
1997-05-06 |
2000-07-18 |
Imarx Pharmaceutical Corp. |
Lipid soluble steroid prodrugs
|
|
US7452551B1
(en)
|
2000-10-30 |
2008-11-18 |
Imarx Therapeutics, Inc. |
Targeted compositions for diagnostic and therapeutic use
|
|
US6416740B1
(en)
|
1997-05-13 |
2002-07-09 |
Bristol-Myers Squibb Medical Imaging, Inc. |
Acoustically active drug delivery systems
|
|
JP4656675B2
(ja)
*
|
1997-05-14 |
2011-03-23 |
ユニバーシティー オブ ブリティッシュ コロンビア |
脂質小胞への荷電した治療剤の高率封入
|
|
EP2113247A3
(en)
|
1997-05-14 |
2010-05-05 |
The University Of British Columbia |
High efficiency encapsulation of nucleic acids in lipid vesicles
|
|
US6123956A
(en)
*
|
1997-07-10 |
2000-09-26 |
Keith Baker |
Methods for universally distributing therapeutic agents to the brain
|
|
US6306432B1
(en)
|
1997-09-08 |
2001-10-23 |
Chiron Corporation |
High and low load formulations of IGF-I in multivesicular liposomes
|
|
US6548047B1
(en)
|
1997-09-15 |
2003-04-15 |
Bristol-Myers Squibb Medical Imaging, Inc. |
Thermal preactivation of gaseous precursor filled compositions
|
|
ES2373861T3
(es)
|
1997-09-18 |
2012-02-09 |
Pacira Pharmaceuticals, Inc. |
Composiciones anestésicas liposomiales de liberación sostenida.
|
|
DE69828193T2
(de)
*
|
1997-10-31 |
2005-12-01 |
The Board Of Regents Of The University Of Oklahoma, Norman |
Hyaluronan synthase gen und seine verwendung
|
|
CN101113436B
(zh)
*
|
1997-10-31 |
2013-02-06 |
俄克拉何马大学董事会 |
透明质酸合酶基因及其应用
|
|
EP1030652B1
(en)
*
|
1997-11-14 |
2012-04-25 |
Pacira Pharmaceuticals, Inc. |
Production of multivesicular liposomes
|
|
US6123923A
(en)
*
|
1997-12-18 |
2000-09-26 |
Imarx Pharmaceutical Corp. |
Optoacoustic contrast agents and methods for their use
|
|
US20010003580A1
(en)
|
1998-01-14 |
2001-06-14 |
Poh K. Hui |
Preparation of a lipid blend and a phospholipid suspension containing the lipid blend
|
|
US6727079B1
(en)
*
|
1998-02-25 |
2004-04-27 |
The United States Of America As Represented By The Department Of Health And Human Services |
cDNA encoding a gene BOG (B5T Over-expressed Gene) and its protein product
|
|
US20060188966A1
(en)
*
|
1998-04-02 |
2006-08-24 |
Deangelis Paul L |
Natural, chimeric and hybrid glycosaminoglycan polymers and methods of making and using same
|
|
US7223571B2
(en)
*
|
1998-04-02 |
2007-05-29 |
The Board Of Regents Of The Universtiy Of Oklahoma |
Targeted glycosaminoglycan polymers by polymer grafting and methods of making and using same
|
|
US20080108110A1
(en)
*
|
1998-04-02 |
2008-05-08 |
Deangelis Paul L |
Targeted glycosaminoglycan polymers by polymer grafting and methods of making and using same
|
|
US6987023B2
(en)
*
|
1998-04-02 |
2006-01-17 |
The Board Of Regents Of The University Of Oklahoma |
DNA encoding hyaluronan synthase from Pasteurella multocida and methods of use
|
|
US7169410B1
(en)
*
|
1998-05-19 |
2007-01-30 |
Sdg, Inc. |
Targeted liposomal drug delivery system
|
|
US7094581B2
(en)
*
|
1998-10-26 |
2006-08-22 |
The Board Of Regents Of The University Of Oklahoma |
Hyaluronan synthases and methods of making and using same
|
|
US6992081B2
(en)
|
2000-03-23 |
2006-01-31 |
Elan Pharmaceuticals, Inc. |
Compounds to treat Alzheimer's disease
|
|
DE60124080T2
(de)
*
|
2000-03-23 |
2007-03-01 |
Elan Pharmaceuticals, Inc., San Francisco |
Verbindungen und verfahren zur behandlung der alzheimerschen krankheit
|
|
US20050287638A1
(en)
*
|
2000-04-25 |
2005-12-29 |
Weigel Paul H |
Hyaluronan receptor for endocytosis, variants thereof, and methods of making and using same
|
|
US6846813B2
(en)
*
|
2000-06-30 |
2005-01-25 |
Pharmacia & Upjohn Company |
Compounds to treat alzheimer's disease
|
|
EP1299352B1
(en)
|
2000-06-30 |
2005-12-28 |
Elan Pharmaceuticals, Inc. |
Compounds to treat alzheimer's disease
|
|
US20030096864A1
(en)
*
|
2000-06-30 |
2003-05-22 |
Fang Lawrence Y. |
Compounds to treat alzheimer's disease
|
|
PE20020276A1
(es)
|
2000-06-30 |
2002-04-06 |
Elan Pharm Inc |
COMPUESTOS DE AMINA SUSTITUIDA COMO INHIBIDORES DE ß-SECRETASA PARA EL TRATAMIENTO DE ALZHEIMER
|
|
CA2427467C
(en)
*
|
2000-11-09 |
2010-01-12 |
Neopharm, Inc. |
Sn-38 lipid complexes and methods of use
|
|
US20110301569A1
(en)
|
2001-01-20 |
2011-12-08 |
Gordon Wayne Dyer |
Methods and apparatus for the CVCS
|
|
US20020150566A1
(en)
*
|
2001-03-23 |
2002-10-17 |
Kun-Liang Guan |
Method of inhibiting cancerous cell proliferation using Ras mutants of GDP-bound conformation
|
|
WO2003030864A1
(en)
*
|
2001-05-29 |
2003-04-17 |
Neopharm, Inc. |
Liposomal formulation of irinotecan
|
|
WO2003002122A1
(en)
*
|
2001-06-27 |
2003-01-09 |
Elan Pharmaceuticals, Inc. |
Beta-hydroxyamine derivatives useful in treatment of alzheimer's disease
|
|
US20030068361A1
(en)
*
|
2001-10-09 |
2003-04-10 |
Rimona Margalit |
Liposome-encapsulated insulin formulations
|
|
BRPI0105509B8
(pt)
|
2001-11-05 |
2021-05-25 |
Univ Minas Gerais |
formulações do peptídeo angiotensina-(1-7) usando as ciclodextrinas, lipossomas e o polímero plga
|
|
EP1441763A2
(en)
*
|
2001-11-07 |
2004-08-04 |
Inex Pharmaceuticals Corp. |
Mucosal adjuvants comprising an oligonucleotide and a cationic lipid
|
|
US7476400B2
(en)
*
|
2001-11-13 |
2009-01-13 |
Ferndale Ip, Inc. |
High-concentration lidocaine compositions and methods for their preparation
|
|
US20070020737A1
(en)
*
|
2001-12-03 |
2007-01-25 |
Pummill Philip E |
Hyaluronan synthases and methods of making and using same
|
|
US20030134423A1
(en)
*
|
2002-01-04 |
2003-07-17 |
Chu Yong Liang |
Compounds for delivering substances into cells
|
|
AU2003205048B2
(en)
*
|
2002-01-09 |
2009-02-26 |
Transave, Inc. |
Efficient liposomal encapsulation
|
|
US20030180348A1
(en)
*
|
2002-03-22 |
2003-09-25 |
Levinson R. Saul |
Transcellular drug delivery system
|
|
US20040013649A1
(en)
*
|
2002-05-10 |
2004-01-22 |
Inex Pharmaceuticals Corporation |
Cancer vaccines and methods of using the same
|
|
US20040009943A1
(en)
*
|
2002-05-10 |
2004-01-15 |
Inex Pharmaceuticals Corporation |
Pathogen vaccines and methods for using the same
|
|
AU2003296897A1
(en)
*
|
2002-08-20 |
2004-05-04 |
Neopharm, Inc. |
Pharmaceutical formulations of camptothecine derivatives
|
|
US20060030578A1
(en)
*
|
2002-08-20 |
2006-02-09 |
Neopharm, Inc. |
Pharmaceutically active lipid based formulation of irinotecan
|
|
EP2823820B1
(en)
|
2002-10-29 |
2018-06-06 |
Insmed Incorporated |
Liposomes comprising an aminoglycoside for the treatment of pulmonary infections
|
|
AU2003293140A1
(en)
*
|
2002-11-26 |
2004-06-18 |
Gilead Sciences, Inc. |
Method of drug loading in liposomes by gradient
|
|
US6866856B2
(en)
*
|
2002-12-31 |
2005-03-15 |
Avon Products, Inc. |
Compositions and delivery methods for the treatment of wrinkles, fine lines and hyperhidrosis
|
|
US20070248541A1
(en)
*
|
2003-12-01 |
2007-10-25 |
Mitsubishi Pharma Corporation |
Liposome
|
|
US7504385B2
(en)
*
|
2003-12-17 |
2009-03-17 |
Avon Products, Inc. |
si-RNA-mediated gene silencing technology to inhibit tyrosinase and reduce pigmentation
|
|
PT1744764E
(pt)
|
2004-04-22 |
2012-08-30 |
Celator Pharmaceuticals Inc |
Formulações lipossómicas de agentes antraciclina e análogos de citidina
|
|
CA2574767C
(en)
|
2004-07-19 |
2015-02-17 |
Celator Pharmaceuticals, Inc. |
Particulate constructs for release of active agents
|
|
CA2584279C
(en)
|
2004-11-05 |
2015-01-27 |
Index Pharmaceuticals Corporation |
Compositions and methods for stabilizing liposomal drug formulations
|
|
KR100651728B1
(ko)
*
|
2004-11-10 |
2006-12-06 |
한국전자통신연구원 |
정착기를 갖는 전자 소자용 화합물 및 이를 포함하는 전자소자와 이들의 제조 방법
|
|
US7459529B2
(en)
|
2004-11-24 |
2008-12-02 |
Seoul National University Industry Foundation |
AIMP2-DX2 and its uses
|
|
US9944713B2
(en)
|
2004-11-24 |
2018-04-17 |
Medicinal Bioconvergence Research Center |
Antibody specific to the AIMP2-DX2
|
|
KR20070104563A
(ko)
*
|
2004-12-20 |
2007-10-26 |
오스트레일리언뉴클리어사이언스앤드테크놀로지오거나이제이션 |
생물학적 존재의 제어된 방출
|
|
AU2005318928B2
(en)
*
|
2004-12-20 |
2010-06-03 |
Australian Nuclear Science & Technology Organisation |
Controlled release of biological entities
|
|
AU2006257727B2
(en)
*
|
2005-06-17 |
2010-09-09 |
Encap Hive Pty Ltd |
Particles comprising a releasable dopant therein
|
|
CN101242814A
(zh)
|
2005-06-17 |
2008-08-13 |
澳大利亚核科学技术组织 |
包含可释放掺杂剂的粒子
|
|
JP2008546614A
(ja)
*
|
2005-06-17 |
2008-12-25 |
オーストラリアン ニュークリア サイエンス アンド テクノロジー オーガニゼーション |
疎水性物質をその中へ含有する粒子
|
|
AU2006257726B2
(en)
*
|
2005-06-17 |
2010-09-09 |
Australian Nuclear Science And Technology Organisation |
Particles having hydrophobic material therein
|
|
JPWO2007032225A1
(ja)
*
|
2005-09-15 |
2009-03-19 |
国立大学法人京都大学 |
リポソーム、リポソームの製造方法及び微小反応空間内での反応制御方法
|
|
JP5336853B2
(ja)
|
2005-11-02 |
2013-11-06 |
プロチバ バイオセラピューティクス インコーポレイティッド |
修飾ｓｉＲＮＡ分子およびその使用法
|
|
US9107824B2
(en)
|
2005-11-08 |
2015-08-18 |
Insmed Incorporated |
Methods of treating cancer with high potency lipid-based platinum compound formulations administered intraperitoneally
|
|
US9149543B2
(en)
*
|
2005-12-15 |
2015-10-06 |
The Trustees Of The University Of Pennsylvania |
Methods and models for rapid, widespread delivery of genetic material to the CNS using non-viral, cationic lipid-mediated vectors
|
|
US20080094573A1
(en)
*
|
2006-04-04 |
2008-04-24 |
Vermette Patrick |
Surface-modified materials, such as contact lenses, methods and kits for their preparation, and uses thereof
|
|
AU2007357448B2
(en)
*
|
2006-09-18 |
2012-09-06 |
Compugen Ltd |
Bioactive peptides and method of using same
|
|
CA2701601C
(en)
|
2006-10-03 |
2020-06-30 |
The Board Of Regents Of The University Of Oklahoma |
Targeted glycosaminoglycan polymers by polymer grafting and methods of making and using same
|
|
EP2155165A1
(en)
*
|
2007-04-20 |
2010-02-24 |
BioCure, Inc. |
Drug delivery vehicle containing vesicles in a hydrogel base
|
|
AU2008273813B2
(en)
|
2007-07-12 |
2013-06-13 |
Compugen Ltd. |
Bioactive peptides and method of using same
|
|
ITRM20070394A1
(it)
*
|
2007-07-16 |
2009-01-17 |
Uni Cattolica Del Sacro Cuo Re |
Liposomi asimmetrici e loro usi in campo medico.
|
|
EP2187869B1
(en)
|
2007-08-17 |
2015-10-14 |
Celator Pharmaceuticals, Inc. |
Improved platinum drug formulations
|
|
CA3043911A1
(en)
|
2007-12-04 |
2009-07-02 |
Arbutus Biopharma Corporation |
Targeting lipids
|
|
EP2229583B1
(en)
|
2007-12-06 |
2019-04-10 |
Genalyte Inc. |
Label-free nucleic acid synthesis monitoring system and method
|
|
US9078812B2
(en)
*
|
2007-12-06 |
2015-07-14 |
The Bay Zoltan Foundation For Applied Research |
Particulate drug carriers as desensitizing agents
|
|
CA2710713C
(en)
|
2007-12-27 |
2017-09-19 |
Protiva Biotherapeutics, Inc. |
Silencing of polo-like kinase expression using interfering rna
|
|
CA2709875C
(en)
|
2008-01-02 |
2019-07-16 |
Tekmira Pharmaceuticals Corporation |
Improved compositions and methods for the delivery of nucleic acids
|
|
PT2279254T
(pt)
|
2008-04-15 |
2017-09-04 |
Protiva Biotherapeutics Inc |
Novas formulações lipídicas para entrega de ácido nucleico
|
|
EP2281041B1
(en)
|
2008-04-15 |
2014-07-02 |
Protiva Biotherapeutics Inc. |
Silencing of csn5 gene expression using interfering rna
|
|
AU2009290396B2
(en)
|
2008-09-11 |
2014-11-06 |
I.B.R. Israeli Biotechnology Research Ltd. |
Leucojum bulb extracts and use thereof
|
|
PL2350043T3
(pl)
|
2008-10-09 |
2014-09-30 |
Tekmira Pharmaceuticals Corp |
Ulepszone aminolipidy i sposoby dostarczania kwasów nukleinowych
|
|
US9846126B2
(en)
|
2008-10-27 |
2017-12-19 |
Genalyte, Inc. |
Biosensors based on optical probing and sensing
|
|
NO2355851T3
(fi)
|
2008-11-10 |
2018-09-01 |
|
|
|
EP3243504A1
(en)
|
2009-01-29 |
2017-11-15 |
Arbutus Biopharma Corporation |
Improved lipid formulation
|
|
EP2395977A2
(en)
|
2009-02-11 |
2011-12-21 |
Lyka Labs Limited |
Liposomal citicoline injection
|
|
CN102421900B
(zh)
|
2009-03-12 |
2015-07-22 |
阿尔尼拉姆医药品有限公司 |
用于抑制Eg5和VEGF基因表达的脂质配制的组合物以及方法
|
|
JP5487666B2
(ja)
*
|
2009-03-23 |
2014-05-07 |
コニカミノルタ株式会社 |
内水相を固定化することを特徴とするリポソームの製造方法
|
|
JP5889783B2
(ja)
|
2009-05-05 |
2016-03-22 |
テクミラ ファーマシューティカルズ コーポレイションＴｅｋｍｉｒａ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｃｏｒｐｏｒａｔｉｏｎ |
免疫細胞へオリゴヌクレオチドを送達する方法
|
|
WO2010129709A1
(en)
|
2009-05-05 |
2010-11-11 |
Alnylam Pharmaceuticals, Inc. |
Lipid compositions
|
|
KR20230098713A
(ko)
|
2009-06-10 |
2023-07-04 |
알닐람 파마슈티칼스 인코포레이티드 |
향상된 지질 조성물
|
|
CA2767127A1
(en)
|
2009-07-01 |
2011-01-06 |
Protiva Biotherapeutics, Inc. |
Novel lipid formulations for delivery of therapeutic agents to solid tumors
|
|
US8716464B2
(en)
|
2009-07-20 |
2014-05-06 |
Thomas W. Geisbert |
Compositions and methods for silencing Ebola virus gene expression
|
|
FR2948035B1
(fr)
*
|
2009-07-20 |
2015-04-24 |
Centre Nat Rech Scient |
Procede de fabrication de capsules, capsules ainsi obtenues et utilisation desdites capsules
|
|
AP3574A
(en)
|
2009-08-14 |
2016-02-08 |
Alnylam Pharmaceuticals Inc |
Lipid formulated compositions and methods for inhibiting expression of a gene from the ebola virus
|
|
US9222086B2
(en)
|
2009-09-23 |
2015-12-29 |
Protiva Biotherapeutics, Inc. |
Compositions and methods for silencing genes expressed in cancer
|
|
WO2011056682A1
(en)
|
2009-10-27 |
2011-05-12 |
The University Of British Columbia |
Reverse head group lipids, lipid particle compositions comprising reverse headgroup lipids, and methods for the delivery of nucleic acids
|
|
EP3296398A1
(en)
|
2009-12-07 |
2018-03-21 |
Arbutus Biopharma Corporation |
Compositions for nucleic acid delivery
|
|
US20130017223A1
(en)
|
2009-12-18 |
2013-01-17 |
The University Of British Columbia |
Methods and compositions for delivery of nucleic acids
|
|
WO2011141704A1
(en)
|
2010-05-12 |
2011-11-17 |
Protiva Biotherapeutics, Inc |
Novel cyclic cationic lipids and methods of use
|
|
EP2569276B1
(en)
|
2010-05-12 |
2021-02-24 |
Arbutus Biopharma Corporation |
Novel cationic lipids and methods of use thereof
|
|
CA2800401C
(en)
|
2010-06-03 |
2020-09-15 |
Alnylam Pharmaceuticals, Inc. |
Biodegradable lipids for the delivery of active agents
|
|
WO2012016184A2
(en)
|
2010-07-30 |
2012-02-02 |
Alnylam Pharmaceuticals, Inc. |
Methods and compositions for delivery of active agents
|
|
WO2012016188A2
(en)
|
2010-07-30 |
2012-02-02 |
Alnylam Pharmaceuticals, Inc. |
Methods and compositions for delivery of active agents
|
|
WO2012061778A2
(en)
|
2010-11-05 |
2012-05-10 |
Genalyte, Inc. |
Optical analyte detection systems and methods of use
|
|
US8518871B2
(en)
|
2010-11-09 |
2013-08-27 |
The Regents Of The University Of California |
Skin permeating and cell entering (SPACE) peptides and methods of use thereof
|
|
DK3202760T3
(da)
|
2011-01-11 |
2019-11-25 |
Alnylam Pharmaceuticals Inc |
Pegylerede lipider og deres anvendelse til lægemiddelfremføring
|
|
EP2907504B1
(en)
|
2011-02-08 |
2017-06-28 |
Halozyme, Inc. |
Composition and lipid formulation of a hyaluronan-degrading enzyme and the use thereof for treatment of benign prostatic hyperplasia
|
|
EP2729127B1
(en)
|
2011-07-04 |
2018-05-02 |
Statens Serum Institut |
Methods for producing liposomes
|
|
EP2760477B1
(en)
|
2011-09-27 |
2018-08-08 |
Alnylam Pharmaceuticals, Inc. |
Di-aliphatic substituted pegylated lipids
|
|
JP2014533953A
(ja)
|
2011-11-17 |
2014-12-18 |
ザ ユナイテッド ステイツ オブ アメリカ， アズ リプレゼンテッド バイ ザ セクレタリー， デパートメント オブ ヘルス アンド ヒューマン サービシーズ |
治療用ｒｎａスイッチ組成物及び使用方法
|
|
EP2606897A1
(en)
|
2011-12-22 |
2013-06-26 |
Laboratorios Del. Dr. Esteve, S.A. |
Methods and compositions for the treatment of diseases caused by enveloped viruses
|
|
US9035039B2
(en)
|
2011-12-22 |
2015-05-19 |
Protiva Biotherapeutics, Inc. |
Compositions and methods for silencing SMAD4
|
|
AU2013222179B2
(en)
|
2012-02-24 |
2017-08-24 |
Arbutus Biopharma Corporat ion |
Trialkyl cationic lipids and methods of use thereof
|
|
EP3907506A1
(en)
|
2012-03-12 |
2021-11-10 |
The Board of Trustees of the University of Illinois |
Optical analyte detection systems with magnetic enhancement and methods of their use
|
|
EP2666456A1
(en)
|
2012-05-21 |
2013-11-27 |
Natura Bisse International, S.A. |
Cometic compositions comprising magnetosomes and uses thereof
|
|
US11291644B2
(en)
|
2012-09-04 |
2022-04-05 |
Eleison Pharmaceuticals, Llc |
Preventing pulmonary recurrence of cancer with lipid-complexed cisplatin
|
|
US20160151284A1
(en)
|
2013-07-23 |
2016-06-02 |
Protiva Biotherapeutics, Inc. |
Compositions and methods for delivering messenger rna
|
|
KR101465365B1
(ko)
*
|
2013-10-15 |
2014-11-25 |
성균관대학교산학협력단 |
리포좀 내 고분자 충진된 다중 기능 복합 입자체 및 이의 제조방법
|
|
KR101638156B1
(ko)
|
2013-10-29 |
2016-07-08 |
가톨릭대학교 산학협력단 |
C형 간염 바이러스 감염 질환의 예방 또는 치료용 약학 조성물
|
|
ES2727137T3
(es)
|
2014-08-28 |
2019-10-14 |
Halozyme Inc |
Terapia combinada con una enzima de degradación de hialuronano y un inhibidor de puntos de control inmunitario
|
|
KR20170075742A
(ko)
|
2014-10-02 |
2017-07-03 |
프로티바 바이오쎄라퓨틱스, 인코포레이티드 |
B형 간염 바이러스 유전자 발현을 제거하는 조성물 및 방법
|
|
EP3234141A4
(en)
|
2014-12-18 |
2018-06-20 |
Alnylam Pharmaceuticals, Inc. |
Reversir tm compounds
|
|
JP6316182B2
(ja)
|
2014-12-19 |
2018-04-25 |
富士フイルム株式会社 |
リポソームの製造方法及びリポソーム製造装置
|
|
EP3240579B1
(en)
|
2014-12-31 |
2022-07-27 |
Lantheus Medical Imaging, Inc. |
Lipid-encapsulated gas microsphere compositions and related methods
|
|
EP4212148A1
(en)
|
2015-05-26 |
2023-07-19 |
Plumb Pharmaceuticals, Inc. |
Liposome loading
|
|
US20180245074A1
(en)
|
2015-06-04 |
2018-08-30 |
Protiva Biotherapeutics, Inc. |
Treating hepatitis b virus infection using crispr
|
|
WO2017019891A2
(en)
|
2015-07-29 |
2017-02-02 |
Protiva Biotherapeutics, Inc. |
Compositions and methods for silencing hepatitis b virus gene expression
|
|
US10429302B2
(en)
|
2015-08-11 |
2019-10-01 |
Scintillon Institute For Biomedical And Bioenergy Research |
Optical analyses of particles and vesicles
|
|
WO2017027760A1
(en)
|
2015-08-12 |
2017-02-16 |
North Carolina State University |
Platelet membrane-coated drug delivery system
|
|
AU2017206077B2
(en)
|
2016-01-08 |
2021-11-18 |
The Regents Of The University Of California |
Mesoporous silica nanoparticles with lipid bilayer coating for cargo delivery
|
|
US10188749B2
(en)
|
2016-04-14 |
2019-01-29 |
Fred Hutchinson Cancer Research Center |
Compositions and methods to program therapeutic cells using targeted nucleic acid nanocarriers
|
|
CR20180503A
(es)
|
2016-04-14 |
2018-12-21 |
Hutchinson Fred Cancer Res |
Composiciones y métodos para programar células terapéuticas utilizando nanoportadores de ácidos nucleicos dirigidos
|
|
TWI832081B
(zh)
|
2016-05-04 |
2024-02-11 |
美商藍瑟斯醫學影像公司 |
用於形成充氣微球體及成像個體之方法、震盪裝置及電腦可讀軟體
|
|
AU2017286980B2
(en)
|
2016-06-30 |
2023-10-26 |
Arbutus Biopharma Corporation |
Compositions and methods for delivering messenger RNA
|
|
US9789210B1
(en)
|
2016-07-06 |
2017-10-17 |
Lantheus Medical Imaging, Inc. |
Methods for making ultrasound contrast agents
|
|
JP7295360B2
(ja)
|
2016-12-21 |
2023-06-21 |
モナーク・バイオサイエンシズ・インコーポレイテッド |
固形腫瘍細胞及びエスケープバリアントを治療するための足場
|
|
EP3565535A4
(en)
|
2017-01-05 |
2020-12-30 |
Fred Hutchinson Cancer Research Center |
SYSTEMS AND METHODS FOR IMPROVING THE EFFECTIVENESS OF A VACCINE
|
|
TW201936201A
(zh)
|
2017-12-14 |
2019-09-16 |
美商堅固生物科技公司 |
基因之非病毒生產及遞送
|
|
WO2020255062A1
(en)
|
2019-06-20 |
2020-12-24 |
Janssen Sciences Ireland Unlimited Company |
Lipid nanoparticle or liposome delivery of hepatitis b virus (hbv) vaccines
|
|
US20210023023A1
(en)
*
|
2019-07-25 |
2021-01-28 |
Vasayo, Llc |
Liposomal nutraceutical compositions and methods of making the same
|
|
US20230150926A1
(en)
|
2020-03-17 |
2023-05-18 |
Genevant Sciences Gmbh |
Cationic lipids for lipid nanoparticle delivery of therapeutics to hepatic stellate cells
|
|
TW202245809A
(zh)
|
2020-12-18 |
2022-12-01 |
美商詹森藥物公司 |
用於治療b型肝炎病毒感染之組合療法
|
|
US11278494B1
(en)
|
2021-01-22 |
2022-03-22 |
Pacira Pharmaceuticals, Inc. |
Manufacturing of bupivacaine multivesicular liposomes
|
|
US11033495B1
(en)
|
2021-01-22 |
2021-06-15 |
Pacira Pharmaceuticals, Inc. |
Manufacturing of bupivacaine multivesicular liposomes
|
|
US11357727B1
(en)
|
2021-01-22 |
2022-06-14 |
Pacira Pharmaceuticals, Inc. |
Manufacturing of bupivacaine multivesicular liposomes
|
|
WO2022212863A1
(en)
|
2021-04-01 |
2022-10-06 |
Vestaron Corporation |
Liposome formulations for pesticide delivery and methods for producing and using the same
|
|
WO2023018990A2
(en)
|
2021-08-12 |
2023-02-16 |
Life Technologies Corporation |
Lipids for nucleic acid delivery
|
|
WO2023144798A1
(en)
|
2022-01-31 |
2023-08-03 |
Genevant Sciences Gmbh |
Ionizable cationic lipids for lipid nanoparticles
|
|
AU2023211981A1
(en)
|
2022-01-31 |
2024-08-15 |
Genevant Sciences Gmbh |
Poly(alkyloxazoline)-lipid conjugates and lipid particles containing same
|
|
WO2023233290A1
(en)
|
2022-05-31 |
2023-12-07 |
Janssen Sciences Ireland Unlimited Company |
Rnai agents targeting pd-l1
|
|
NL2035417B9
(en)
|
2022-07-19 |
2024-10-09 |
Coty Inc |
Cosmetic composition
|
|
WO2024031051A1
(en)
|
2022-08-05 |
2024-02-08 |
Life Technologies Corporation |
Lipids for nucleic acid delivery
|
|
WO2024168010A2
(en)
|
2023-02-09 |
2024-08-15 |
Alnylam Pharmaceuticals, Inc. |
Reversir molecules and methods of use thereof
|
|
WO2024209267A2
(en)
|
2023-04-03 |
2024-10-10 |
Jazz Pharmaceuticals Ireland Limited |
Modulators of nanoparticle uptake
|